Literature DB >> 7536037

Synthesis and interaction of fluorescent thapsigargin derivatives with the sarcoplasmic reticulum ATPase membrane-bound region.

S Hua1, H Malak, J R Lakowicz, G Inesi.   

Abstract

Fluorescent derivatives of thapsigargin (TG) were synthesized by replacing the C8-butanoyl chain with a dansyl (DTG) or eosin (ETG) moiety. DTG and ETG retain the inhibitory effect of TG on the sarcoplasmic reticulum (SR) ATPase, displaying a 2 and 10 microM Ki, respectively. Steady state and lifetime fluorescence measurements are consistent with energy transfer between tryptophanyl residues assigned to the ATPase membrane-bound region and DTG. This phenomenon exhibits saturation behavior, occurs in the presence of DTG concentrations producing ATPase inhibition, and is partially prevented by inhibitory concentrations of TG. Although long range conformational effects of TG binding affect the fluorescence properties of endogenous tryptophans as well as of a fluorescein 5'-isothiocyanate (FITC) label of the ATPase extramembranous region, no significant energy transfer was detected between DTG and the FITC label. It is concluded that the inhibitors partition within the membrane and the binding domain resides within or near the membrane-bound region of the ATPase.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7536037     DOI: 10.1021/bi00015a026

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  3 in total

1.  Design, synthesis, and biological evaluation of hydroquinone derivatives as novel inhibitors of the sarco/endoplasmic reticulum calcium ATPase.

Authors:  Stefan Paula; Josh Abell; Joel Deye; Christopher Elam; Michael Lape; Justin Purnell; Robert Ratliff; Kelly Sebastian; Jodie Zultowsky; Robert J Kempton
Journal:  Bioorg Med Chem       Date:  2009-08-04       Impact factor: 3.641

Review 2.  Studies of Ca2+ ATPase (SERCA) inhibition.

Authors:  Giuseppe Inesi; Suming Hua; Cheng Xu; Hailun Ma; Malini Seth; Anand M Prasad; Carlota Sumbilla
Journal:  J Bioenerg Biomembr       Date:  2005-12       Impact factor: 3.853

3.  Leukemia-specific delivery of mutant NOTCH1 targeted therapy.

Authors:  Giovanni Roti; Jun Qi; Samuel Kitara; Marta Sanchez-Martin; Amy Saur Conway; Anthony C Varca; Angela Su; Lei Wu; Andrew L Kung; Adolfo A Ferrando; James E Bradner; Kimberly Stegmaier
Journal:  J Exp Med       Date:  2017-11-20       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.